631 filings
Page 18 of 32
8-K
i0wh3lp4jvk5vn64gv2l
30 Dec 11
ONSOLIS to Benefit from Approval of Class-Wide REMS
12:00am
8-K
wbsq14 4puu
21 Dec 11
BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study
12:00am
8-K
ocbnorp98fs
28 Nov 11
US Patent Office Rejects All 191 Claims in Key MonoSol Patent
12:00am
8-K
wjoh9x17chyzdrs09
14 Nov 11
BioDelivery Sciences to Host Business Update Webcast and Conference Call
12:00am
8-K
zz7 szk33
10 Nov 11
Other Events
12:00am
8-K
55v18i9a
7 Nov 11
Other Events
12:00am
8-K
fg1k1qb kpn
25 Oct 11
Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors
12:00am
8-K
y3g00k
30 Sep 11
BioDelivery Sciences Announces Results from Phase 3 Efficacy Study
12:00am
8-K
cybyh1zu
6 Sep 11
BioDelivery Sciences Announces Positive Results Supporting
12:00am
S-8
m4hpt
24 Aug 11
Registration of securities for employees
12:00am
8-K
rhpy31
22 Aug 11
BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada
12:00am
CT ORDER
w6r1sxg
16 Aug 11
Confidential treatment order
12:00am
8-K
ji2hv28j
26 Jul 11
BioDelivery Sciences Announces Completion of
12:00am
8-K
ldkfr945c8uejj41
25 Jul 11
Amendments to Articles of Incorporation or Bylaws
12:00am
DEFA14A
lydye
29 Jun 11
Additional proxy soliciting materials
12:00am
8-K
t18gd crgj
3 Jun 11
BioDelivery Sciences Provides Update
12:00am